Core One Labs Inc.: Core One Labs Signs Definitive Agreement for Acquisition of Biosynthetic Psilocybin Research Firm Vocan Biotechnologies Inc.
Core One Labs Inc.: Core One Labs Signs Definitive Agreement for Acquisition of Biosynthetic Psilocybin Research Firm Vocan Biotechnologies Inc. Core One Labs Inc. (CSE:COOL), (OTC:CLABF), (Frankfurt:LD62), (WKN:A14XHT) (the " Company") is pleased to announce that, further to its press release of October 7, 2020, it has entered into a definitive share purchase agreement (the " Purchase Agreement"), dated December 23, 2020, for the acquisition (the " Acquisition") of all of the outstanding share capital of Vocan Biotechnologies Inc. (" Vocan"), a Canadian-based genetic engineering and biosynth...
Source: finanznachrichten.de